EATG » R&D

R&D

New TAG report: Funding for TB research climbed to new high in 2017

December 3, 2018 – Global funding for tuberculosis (TB) research climbed to a previously unreported high of USD $772 million in 2017, according to a report released today by Treatment…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

2018 Access to Medicine Index

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. Amsterdam, the Netherlands, 20 November…

Continued declines in HIV research funding put global prevention targets at great risk

Madrid, Oct. 25, 2018 – HIV prevention research funding continued to decline in 2017 for the fifth consecutive year, driven largely by a five-year low in US public sector funding, according…

More prevention research needed to control the HIV/AIDS pandemic

Since the beginning of the HIV/AIDS pandemic, investigators have been exploring different avenues of research for how to stop transmission of the virus once and for all. As scientific research…

Effective TB, HIV and malaria vaccines missing from drug development pipeline

Financial modeling tool reveals where global health investment falls short Many of the vaccines critically needed to fight some of the world’s most prevalent infectious diseases are not likely to…

Webinar: Patient Engagement on Medicines Research & Development

Join us for a webinar about patient engagement in the process of research and development of medicines on Thursday, September 6 from 18:00 to 19:15 CET.   Four European patient…

AIDS 2018: Addressing research gaps identified by women living with HIV in Europe and Central Asia

We are pleased to invite you to join a side-meeting at the AIDS 2018 conference that will bring together community, clinicians and researchers to discuss research gaps related to women…

Novartis drops antibiotics research program

Ceasing work on several experimental antimicrobial projects   CIDRAP News: Novartis drops antibiotic development program “Antibiotic development efforts were dealt a blow when drug maker Novartis AG announced its…

Hookipa and Gilead enter into a collaboration and license agreement to develop immunotherapies against HIV and hepatitis B

-- Hookipa and Gilead will jointly develop therapeutics against HIV and Hepatitis B infections -- Hookipa and Gilead will jointly research and Hookipa will manufacture arenavirus-based vectors for clinical development…

1 2 3 7